Bartlett & Co. LLC Ligand Pharmaceuticals Inc Transaction History
Bartlett & Co. LLC
- $6.16 Billion
- Q4 2023
Shares
2 transactions
Others Institutions Holding LGND
# of Institutions
277Shares Held
18.5MCall Options Held
30.8KPut Options Held
5.2K-
Black Rock Inc. New York, NY2.87MShares$311 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$226 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.02MShares$110 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3884KShares$95.6 Million0.11% of portfolio
-
State Street Corp Boston, MA744KShares$80.4 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.83B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...